109 related articles for article (PubMed ID: 11117489)
1. Increased hippocampal supragranular Timm staining in subjects with bipolar disorder.
Dowlatshahi D; MacQueen G; Wang JF; Chen B; Young LT
Neuroreport; 2000 Nov; 11(17):3775-8. PubMed ID: 11117489
[TBL] [Abstract][Full Text] [Related]
2. Analysis of ependymal abnormalities in subjects with schizophrenia, bipolar disorder, and depression.
Gilmore JH; Bouldin TW
Schizophr Res; 2002 Oct; 57(2-3):267-71. PubMed ID: 12223258
[TBL] [Abstract][Full Text] [Related]
3. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication.
Chen B; Dowlatshahi D; MacQueen GM; Wang JF; Young LT
Biol Psychiatry; 2001 Aug; 50(4):260-5. PubMed ID: 11522260
[TBL] [Abstract][Full Text] [Related]
4. Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains.
Dunham JS; Deakin JF; Miyajima F; Payton A; Toro CT
J Psychiatr Res; 2009 Sep; 43(14):1175-84. PubMed ID: 19376528
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of glutamate carboxypeptidase II in psychiatric disease.
Guilarte TR; Hammoud DA; McGlothan JL; Caffo BS; Foss CA; Kozikowski AP; Pomper MG
Schizophr Res; 2008 Feb; 99(1-3):324-32. PubMed ID: 18191545
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical characterization of mossy fibre sprouting in the hippocampus of patients with pharmaco-resistant temporal lobe epilepsy.
Proper EA; Oestreicher AB; Jansen GH; Veelen CW; van Rijen PC; Gispen WH; de Graan PN
Brain; 2000 Jan; 123 ( Pt 1)():19-30. PubMed ID: 10611117
[TBL] [Abstract][Full Text] [Related]
7. Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of complexin mRNAs.
Eastwood SL; Harrison PJ
Mol Psychiatry; 2000 Jul; 5(4):425-32. PubMed ID: 10889554
[TBL] [Abstract][Full Text] [Related]
8. Increased densities of AMPA GluR1 subunit proteins and presynaptic mossy fiber sprouting in the fascia dentata of human hippocampal epilepsy.
Ying Z; Babb TL; Comair YG; Bushey M; Touhalisky K
Brain Res; 1998 Jul; 798(1-2):239-46. PubMed ID: 9666139
[TBL] [Abstract][Full Text] [Related]
9. Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium.
Knable MB; Barci BM; Webster MJ; Meador-Woodruff J; Torrey EF;
Mol Psychiatry; 2004 Jun; 9(6):609-20, 544. PubMed ID: 14708030
[TBL] [Abstract][Full Text] [Related]
10. Immunoreactivity of 43 kDa growth-associated protein is decreased in post mortem hippocampus of bipolar disorder and schizophrenia.
Tian SY; Wang JF; Bezchlibnyk YB; Young LT
Neurosci Lett; 2007 Jan; 411(2):123-7. PubMed ID: 17095155
[TBL] [Abstract][Full Text] [Related]
11. Altered levels of the synaptosomal associated protein SNAP-25 in hippocampus of subjects with mood disorders and schizophrenia.
Fatemi SH; Earle JA; Stary JM; Lee S; Sedgewick J
Neuroreport; 2001 Oct; 12(15):3257-62. PubMed ID: 11711867
[TBL] [Abstract][Full Text] [Related]
12. Consequences of recurrent seizures during early brain development.
Liu Z; Yang Y; Silveira DC; Sarkisian MR; Tandon P; Huang LT; Stafstrom CE; Holmes GL
Neuroscience; 1999; 92(4):1443-54. PubMed ID: 10426498
[TBL] [Abstract][Full Text] [Related]
13. Altered myelination of the hippocampal formation in subjects with schizophrenia and bipolar disorder.
Chambers JS; Perrone-Bizzozero NI
Neurochem Res; 2004 Dec; 29(12):2293-302. PubMed ID: 15672553
[TBL] [Abstract][Full Text] [Related]
14. Hippocampal α7 nicotinic acetylcholine receptor levels in patients with schizophrenia, bipolar disorder, or major depressive disorder.
Thomsen MS; Weyn A; Mikkelsen JD
Bipolar Disord; 2011; 13(7-8):701-7. PubMed ID: 22085484
[TBL] [Abstract][Full Text] [Related]
15. Hippocampal CA1 pyramidal cell size is reduced in bipolar disorder.
Liu L; Schulz SC; Lee S; Reutiman TJ; Fatemi SH
Cell Mol Neurobiol; 2007 May; 27(3):351-8. PubMed ID: 17235693
[TBL] [Abstract][Full Text] [Related]
16. Common proteomic changes in the hippocampus in schizophrenia and bipolar disorder and particular evidence for involvement of cornu ammonis regions 2 and 3.
Föcking M; Dicker P; English JA; Schubert KO; Dunn MJ; Cotter DR
Arch Gen Psychiatry; 2011 May; 68(5):477-88. PubMed ID: 21536977
[TBL] [Abstract][Full Text] [Related]
17. Seizures, cell death, and mossy fiber sprouting in kainic acid-treated organotypic hippocampal cultures.
Routbort MJ; Bausch SB; McNamara JO
Neuroscience; 1999; 94(3):755-65. PubMed ID: 10579566
[TBL] [Abstract][Full Text] [Related]
18. Volume, metabolites and neuroinflammation of the hippocampus in bipolar disorder - A combined magnetic resonance imaging and positron emission tomography study.
Haarman BC; Burger H; Doorduin J; Renken RJ; Sibeijn-Kuiper AJ; Marsman JB; de Vries EF; de Groot JC; Drexhage HA; Mendes R; Nolen WA; Riemersma-Van der Lek RF
Brain Behav Immun; 2016 Aug; 56():21-33. PubMed ID: 26348581
[TBL] [Abstract][Full Text] [Related]
19. Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia.
Vawter MP; Thatcher L; Usen N; Hyde TM; Kleinman JE; Freed WJ
Mol Psychiatry; 2002; 7(6):571-8. PubMed ID: 12140780
[TBL] [Abstract][Full Text] [Related]
20. Hippocampal volume and cell number in depression, schizophrenia, and suicide subjects.
Chen F; Bertelsen AB; Holm IE; Nyengaard JR; Rosenberg R; Dorph-Petersen KA
Brain Res; 2020 Jan; 1727():146546. PubMed ID: 31715144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
